search
for
 About Bioline  All Journals  Testimonials  Membership  News


Medical Journal of The Islamic Republic of Iran
National Research Centre of Medical Sciences of I.R. IRAN
ISSN: 1016-1430
Vol. 20, No. 2, 2006, pp. 86-92 		Bioline Code: mr06020
Full paper language: English
Document type: Research Article
Document available free of charge

Medical Journal of The Islamic Republic of Iran, Vol. 20, No. 2, 2006, pp. 86-92

 en SAFETY OF BLOOD AND PLASMA DERIVATIVES: PATHOGEN REDUCING TECHNOLOGIES
REZVAN, H.; MOTALLEBI, Z.; JALILI, M. A.; MOUSAVI HOSSEINI, K. & POURFATHOLLAH, A. A.

Abstract

Human blood and blood products is the source of a wide range of medicinal products used for the treatment and prevention of a variety of injuries and disease. Despite stringent routine measures and filters employed, residual pathogen infectivity remains an important challenge in the field of blood transfusion. In this article various measures and technologies that can be applied in order to reduce the residual risk are reviewed.

Keywords
Plasma derivatives ;Virus inactivation; blood borne viruses.

 
© Copyright 2006 -Medical Journal of the Islamic Republic of Iran
Alternative site location: http://mjiri.iums.ac.ir/index.php/mjiri

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil